Current Issue
Mid-November 2023
Information Infusion: ASH 2023
With sessions covering everything from artificial intelligence to physician burnout, the 2023 ASH Annual Meeting includes topics that are front of mind for hematologists around the world.
Viewpoints
Editor’s Corner
Science Fiction Meets Hematology: Large Language Models in Clinical Practice
From the Desk Of... Videos
From the Desk Of... November 2023
Education
Hematologica Obscura
Hematologists Should Take Primary Management Role in HHT
Spotlight
pASHions
Hitting the Right Notes: Meet the Adverse Events
2023 ASH Annual Meeting Preview
Spreading the Word About Supplemental Funding for SCD Centers
Maternal Health: An Issue for Patients and the Physicians Who Care for Them
Exploring the Potential of AI in Drug Development, Clinical Decisions
Digging Deeper Into the Role, Impact of Race on Research, Outcomes
Crowd-Sourced Topics, Cross-Disciplinary Sessions Are Highlights of Scientific Program
Education Program to Focus on Diverse Views, Latest Advancements in Hematologic Care
Focusing on Sustainable Care to Improve Patients’ Overall Well-Being
News
Latest and Greatest
FDA Approves Treatment to Help Patients with MM Receive Hematopoietic Cell Transplants
MDS Treatment Granted Priority Review
Study Finds Fracking May Be Tied to Pediatric Lymphoma
CMS Names First 10 Drugs Eligible for Price Negotiations
Written in Blood
No Change in Platelet Count Threshold of Patients With ITP Treated With Aspirin
TP53 Status May Hint at Acute Myeloid Leukemia Prognosis
Blood Advances in a Different Vein
Diagnosing Cancer Can Be Tricky: One-Third of MDS Diagnoses Reclassified in Study
Meta-Analysis Narrows Most Efficacious Agents for Acquired Pure Red Cell Aplasia
Pacritinib Is One Option for Patients with Myelofibrosis and Anemia
Literature Scan
Eligibility Criteria Can Limit Patient Access
MPN Linked to Lower Death and Cardiac Arrest, Higher Bleeding in Patients Hospitalized With AMI
Data Stream
Connect with us:
CURRENT ISSUE
Mid-November 2023
